SQUARE IMPRINT
Generic Name: rizatriptan
Pill imprint SQUARE IMPRINT has been identified as Maxalt-MLT 10 mg.
Maxalt-MLT is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy.
Maxalt-MLT 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Maxalt-MLT Images
- Generic Name:
- rizatriptan
- Imprint:
-
SQUARE IMPRINT
- Strength:
- 10 mg
- Color:
- White
- Size:
- 14.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- gelatin
mannitol
glycine
aspartame
- Drug Class:
- Antimigraine agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Merck & Company Inc.
- National Drug Code (NDC):
- 00006-3801
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4499 | Physicians Total Care Inc (repackager) |
| 68115-0882 | Dispensexpress Inc (repackager) |
| 35356-0275 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Maxalt-MLT resources
- Maxalt-MLT Orally Disintegrating Tablets (Wolters Kluwer)
- Maxalt-MLT (Cerner Multum)
- Maxalt-MLT (Micromedex) - Includes Dosage Information
Search Again
